Clinical Challenges in Catecholaminergic Polymorphic Ventricular Tachycardia

Area of Science:

• Cardiology
• Genetics
• Electrophysiology

Background:

• Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmia syndrome.
• It is a significant cause of sudden cardiac death in young individuals, often triggered by exercise or stress.
• Despite advancements, key aspects of CPVT remain poorly understood.

Purpose of the Study:

• To address the current knowledge gaps in the epidemiology, diagnosis, and management of CPVT.
• To highlight the challenges faced by cardiologists in managing CPVT patients.
• To emphasize the need for novel diagnostic, prognostic, and therapeutic strategies.

Main Methods:

• This review synthesizes current literature on CPVT.
• It analyzes epidemiological data, diagnostic challenges, and treatment outcomes.
• It discusses the limitations of existing diagnostic tools and therapeutic interventions.

Main Results:

• The true prevalence of CPVT is unknown and likely underestimated.
• Genetic testing confirms diagnosis in only about 50% of cases.
• A significant portion of CPVT patients experience persistent arrhythmias despite beta-blocker therapy.

Conclusions:

• CPVT diagnosis and management remain challenging for cardiologists.
• Further research is crucial to elucidate the role of emerging therapies like flecainide and left cardiac sympathetic denervation.
• Development of new diagnostic and therapeutic approaches is essential for improving outcomes in CPVT patients.